Immunization update.
Although the development and licensure of new vaccines over the last 2 years has generated a lot of excitement as well as debate, there is a lot more to come. Not discussed in this article. licensure of another long-awaited vaccine albeit for use in adults was that for herpes zoster. The second HPV and rotavirus vaccines are awaiting approval in the US. Next in line are the vaccines both prophylactic as well as therapeutic against HIV. Topics of debate over the new vaccines include discussions amongst practices as to the affordability and cost of the new vaccines as well as the ethical debate amongst lawmakers and the general public regarding the rights and wrongs of compulsory vaccination against HPV. Another ongoing discussion is regarding the availability of approved vaccines. Shortages have been seen with several of the childhood vaccines including heptavalent pneumococcal conjugate vaccine, tetravalent meningococcal conjugate vaccine, hepatitis A vaccine, as well as the ongoing saga with influenza vaccines. Across the globe while the struggle against polio continues, there is encouraging news regarding the reduction in measles-related deaths, particularly in Africa. The last few years have indeed been landmark years in infectious disease research as the search continues for better and safer vaccines globally.
Mirza
Ayesha
A
Pediatric Infectious Diseases and Immunology, University of Florida, 653-1 West 8th Street, L-13, Jacksonville, FL 32209, USA.
Rathore
Mobeen H
MH
D000293:Adolescent; D000349:Africa; D001428:Bacterial Vaccines / Q000145:classification; D002648:Child; D014943:Global Health; D006801:Humans; D007114:Immunization; D007115:Immunization Schedule; D014481:United States; D014611:Vaccination; D014612:Vaccines / Q000008:administration & dosage*; D014765:Viral Vaccines / Q000145:classification
D001428:Bacterial Vaccines; D014612:Vaccines; D014765:Viral Vaccines